Germany’s Fresenius weighing bid for generic drugmaker Akorn: Bbg

Apr 7, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

(Reuters) – German healthcare group Fresenius SE & Co KGaA is weighing a bid for generic drugmaker Akorn Inc , Bloomberg reported on Friday, citing people familiar with the matter.